Abstract:The aim of this study was to find the application value of selective polyadenylation in immune cell infiltration, biological transcription function and risk assessment of survival and prognosis in lung adenocarcinoma (LUAD). The processed original mRNA expression data of LUAD were downloaded, and the expression profiles of 594 patient samples were collected. The (APA) events in TCGA-NA-SEQ data were evaluated by polyadenylation site use Index (PDUI) values, and the invasion of stromal cells and immune cells and tumor purity were calculated to group and select the differential genes. Lasso regression and stratified analysis were used to examine the role of risk scores in predicting patient outcomes. The study also used the GDSC database to predict the chemotherapeutic sensitivity of each tumor sample and used a regression method to obtain an IC50 estimate for each specific chemotherapeutic drug treatment. Then CIBERSORT algorithm was used to conduct Spearman correlation analysis, immune regulatory factor analysis and TIDE immune system function analysis for gene expression level and immune cell content. Finally, the Kaplan-Meier curve was used to analyze the correlation between stromal score and the immune score of LUAD. In this study, APA's LUAD risk score prognostic model was constructed. KM survival analysis showed that immune score affected the prognosis of LUAD patients (P = 0.027) but the matrix score was not statistically significant (P = 0.1). We extracted 108 genes with APA events from 827 different genes and based on PUDI clustering and heat map, the survival rate of patients in the four groups was significantly different (P = 0.05). Multiple omics studies showed that risk score was significantly positively correlated with Macrophages M0, T cells Follicular helper, B cells naive and NK cells resting. It is significantly negatively correlated with dendritic cells resting, mast cells resting, monocyte, T cells CD4 memory resting and B cells memory. We further explored the relationship between the expression of immunosuppressor genes and risk score and found that ADORA2A, BTLA, CD160, CD244, CD274, CD96, CSF1R and CTLA4 genes were highly correlated with the risk score. Selective poly adenylation plays an important role in the development and progression of LUAD, immune invasion, tumor cell invasion and metastasis and biological transcription, and affects the survival and prognosis of LUAD patients.

Comprehensive Analysis of Alternative Polyadenylation Events Associated with the Tumor Immune Microenvironment in Colon Adenocarcinoma

Alternative Polyadenylation Associated with Prognosis and Therapy in Colorectal Cancer.

Data from Characterization of Immune-Related Alternative Polyadenylation Events in Cancer Immunotherapy

Characterization of immune-related alternative polyadenylation events in cancer immunotherapy

Down-regulated C4orf19 Confers Poor Prognosis in Colon Adenocarcinoma Identified by Gene Co-Expression Network.

The Identification of Alternative Polyadenylation in Stomach Adenocarcinomas Using the Genotype-Tissue Expression Project and the Cancer Genome Atlas– Stomach Adenocarcinoma Profiles

Alternative polyadenylation shapes the molecular and clinical features of lung adenocarcinoma

Alternative Polyadenylation Modification Patterns Reveal Essential Posttranscription Regulatory Mechanisms of Tumorigenesis in Multiple Tumor Types.

Construction of Prognostic Risk Model for Patients with Colon Adenocarcinoma Based on Immunogenomics Analysis

Integrated RNA expression and alternative polyadenylation analysis identified CPSF1‐CCDC137 oncogenic axis in lung adenocarcinoma

Comprehensive Analysis of Alternative Polyadenylation Regulators Concerning CD276 and Immune Infiltration in Bladder Cancer

A novel APA-based prognostic signature may predict the prognosis of lung adenocarcinoma in an East Asian population

Selective poly adenylation predicts the efficacy of immunotherapy in patients with lung adenocarcinoma by multiple omics research

Identification and analysis of prognostic metabolic characteristics in colon adenocarcinoma

Alternative polyadenylation drives oncogenic gene expression in pancreatic ductal adenocarcinoma

Genetic variants that impact alternative polyadenylation in cancer represent candidate causal risk loci

Genome-wide RNA-sequencing dataset reveals AC096751.1 sever as a novel prognostic long non-coding RNA and its potential molecular mechanisms in patients with colon adenocarcinoma

PANoptosis-related genes function as efficient prognostic biomarkers in colon adenocarcinoma

Identification of Key Biomarkers Associated with Survival and Prognosis in Colon Adenocarcinoma

The anoikis-related gene signature predicts survival accurately in colon adenocarcinoma

Commentary On: Screening of Immunosuppressive Cells from Colorectal Adenocarcinoma and Identification of Prognostic Markers.